Oral Soft Tissue Diseases, 5th Edition, is designed to assist in the diagnosis and management of patients with oral soft tissue diseases.
This is a visually-cued manual, organized into 9 convenient, tabbed sections providing a user-friendly format for the busy dental professional - a perfect chair-side reference.
Some oral soft tissue diseases exhibit distinctive clinical features and require little more than visual recognition to make an accurate diagnosis. Others share common features making an accurate diagnosis more challenging. Recognizing the clinical features most helpful in differentiating one lesion from another is an essential part of the diagnostic process.
In this manual, each lesion is illustrated by one or more color photographs depicting typical clinical features and common variations. Recommendations for treatment and follow-up, including sample prescriptions and concise drug monographs, are included.
- Over 100 Lesions
- 6 Lesions New to this Edition:
- Anesthetic Necrosis
- Eruption Cyst
- Multiple Hamartoma Syndrome
- Transient Lingual Papillitis
- Torus Mandibularis
- Torus Palatinus
- 269 Color Photographs
- Sample Prescription Section
- Updated Antibiotic Prophylaxis-Preprocedural Guidelines for Dental Patients
J. Robert Newland, DDS, MS is a Professor in the Department of Stomatology and Head of the Division of Oral and Maxillofacial Pathology at the University of Texas Health Science Center at Houston, Dental Branch. Dr Newland has been a dental educator for more than 20 years. He is a Fellow in the American Academy of Oral and Maxillofacial Pathology and a Diplomate of the American Board of Oral and Maxillofacial Pathology. Dr Newland graduated from the University of Texas in 1966 and received a Doctor of Dental Surgery Degree from the University of Texas Health Science Center at Houston, Dental Branch in 1970. He completed an Advanced Education Program in Oral Pathology at the University of Texas Health Science Center at Houston, Dental Branch and received a Master of Science Degree in Oral Pathology in 1978. Dr Newland also completed a fellowship in Oral Pathology at the MD Anderson Cancer Center. He has more than 100 publications on a variety of topics related to his specialty, including benign and malignant oral tumors, oral manifestations of AIDS, oral manifestations of systemic diseases, and the diagnosis and treatment of oral soft tissue diseases. Dr Newland has presented more than 100 continuing education seminars to dental and medical professionals. He also maintains an active private practice where he manages patients with oral soft tissue diseases.
Timothy F. Meiller, DDS, PhD is Professor of Oral Medicine and Diagnostic Sciences at the Baltimore College of Dental Surgery and Professor of Oncology in the Program of Oncology at the Greenebaum Cancer Center, University of Maryland, Baltimore. Dr Meiller has held this position in Oral Medicine at the Dental School for 23 years and serves as an attending faculty at the Greenebaum Cancer Center. He is a Diplomate of the American Board of Oral Medicine. He is a graduate of Johns Hopkins University and the University of Maryland Dental and Graduate Schools, holding a DDS and a PhD in Immunology/Virology. He has over 165 publications to his credit. He maintains an active general dental practice and is a consultant to the National Institutes of Health. He is currently engaged in ongoing investigations into cellular immune dysfunction in oral diseases associated with AIDS, in cancer patients, and in other medically-compromised patients.
Richard L. Wynn, BSPharm, PhD is Professor of Pharmacology at the Baltimore College of Dental Surgery, Dental School, University of Maryland at Baltimore. Dr Wynn has served as a dental educator, researcher, and teacher of dental pharmacology and dental hygiene pharmacology for his entire professional career. He holds a BS (pharmacy; registered pharmacist, Maryland), an MS (physiology) and a PhD (pharmacology) from the University of Maryland. Dr Wynn chaired the Department of Pharmacology at the University of Maryland Dental School from 1980 to 1995. Previously, he chaired the Department of Oral Biology at the University of Kentucky College of Dentistry. He has to his credit over 180 publications including original research articles, textbooks, textbook chapters, monographs, and articles in continuing education journals. He has given over 300 continuing education seminars to dental professionals in the U.S., Canada, and Europe. Dr Wynn has been a consultant to the drug industry for 17 years. His research laboratories have contributed to the development of new analgesics and anesthetics. He is a consultant to the U.S. Pharmacopeia, Dental Drugs and Products section, a consultant to the Academy of General Dentistry, a consultant to the American Dental Association, and a former consultant to the Council on Dental Education, Commission on Accreditation. He is a featured columnist and his drug review articles, entitled Pharmacology Today, appear in each issue of General Dentistry, a journal published by the Academy. He is currently funded by drug industry and government agencies for research on the development of new drugs. One of his primary interests continues to be keeping dental professionals informed on all aspects of drug use in dental practice.